How to Reconstitute KGLOW: A Step-by-Step Guide
Reconstituting KGLOW is not identical to reconstituting any other compound in this library. All four components are freely water-soluble and reconstitute together.
In plain English
The 80 mg fill is the thing to watch. Pour in your habitual 2 mL and you land eight times more concentrated than you probably meant. Three millilitres gives about 27 mg/mL overall. And as with GLOW: never an acidic liquid, or the copper comes off.
What KGLOW actually is
KGLOW — also written KLOW — is GLOW with one addition. It contains GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, making 80 mg in total. KPV is a very short three-part molecule taken from a natural hormone, studied for calming inflammation in research models.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥98% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Diluent selection for KGLOW
All four components are freely water-soluble and reconstitute together. As with GLOW the solution is blue, since GHK-Cu is still the majority component at 62.5% by mass. KPV is very small and highly water-soluble, adding no dissolution difficulty. The same pH constraint applies: never use acidic diluent, because it dissociates copper from the GHK-Cu component.
Common reconstitution reference
An 80 mg vial in 3 mL gives ≈27 mg/mL combined — about 16.7 mg/mL GHK-Cu and 3.3 mg/mL each of BPC-157, TB-500 and KPV. Neutral or slightly alkaline diluent only.
Open the KGLOW calculatorMethod notes for this compound
- Never reconstitute in acidic diluent — copper dissociation from the GHK-Cu component is the primary risk.
- Keep EDTA and other chelators out of any buffer used with KGLOW.
- Treat colour as data: clear even blue is correct; pale or green is not.
- Protect from light and minimise headspace exposure for the TB-500 component.
- Scale diluent to the 80 mg fill — habitually adding 2 mL as though to a 10 mg vial gives a solution eight times more concentrated than intended.
What KGLOW is studied for
The majority component, with the deepest dermal research literature.
The addition that distinguishes KGLOW — studied for anti-inflammatory activity derived from alpha-MSH without pigmentation effects.
Two complementary tissue-repair mechanisms, unchanged from GLOW.
Adds an inflammation arm to the three repair-focused mechanisms in GLOW.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More KGLOW reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Reconstitution reference for other compounds
KGLOW is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.